Melinta Therapeutics

On target clinical trial success bullseye score

Pharma

Mundipharma, CorMedix score trial victory for antifungal Rezzayo

Mundipharma and CorMedix have scored in a phase 3 trial of Rezzayo in preventing fungal diseases in patients receiving stem cell transplants.

Kevin Dunleavy Apr 27, 2026 3:52pm

puzzle pieces merger and acquisition business concept

CorMedix buys Melinta for $300M, adding 7 marketed products

Aug 7, 2025 11:36am

Red Light Green Light

FDA says yes to Allecra's antibiotic combo after CRL for another

Feb 27, 2024 11:44am

Acinetobacter

Venatorx, Melinta's antibiotic rejected over manufacturing issues

Feb 23, 2024 10:55am

FDA Building

FDA signs off on Cidara's antifungal Rezzayo for candidiasis

Mar 23, 2023 11:07am

FDA Building 2

Melinta won FDA approval for skin infection fighter Kimyrsa

Mar 15, 2021 12:35pm